Officials from Hopkinton-based Caliper Life Sciences rang the bell to open the trading day on the Nasdaq stock market this morning.
Company executives, family members and customers joined Kevin Hrusovsky, Caliper’s president and CEO to ring the opening bell.
The company has had up-and-down financial returns for the past few quarters. A 25 percent rise in first-quarter revenues year-over-year to $35.8 million was coupled with losses increasing from $2.2 million to $2.6 million.
Last year, the company swung to a $4.3 million profit on $123.7 million in revenues, compared to an $8.2 million loss on $130.4 million in revenues the year before.
The company has also made some acquisitions in recent years, including most recently purchasing Cambridge Research & Instrumentation for $20 million in December.
